TY - JOUR
T1 - Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study)
T2 - a national cross-sectional study
AU - China Pulmonary Health Study Group
AU - Wang, Chen
AU - Xu, Jianying
AU - Yang, Lan
AU - Xu, Yongjian
AU - Zhang, Xiangyan
AU - Bai, Chunxue
AU - Kang, Jian
AU - Ran, Pixin
AU - Shen, Huahao
AU - Wen, Fuqiang
AU - Huang, Kewu
AU - Yao, Wanzhen
AU - Sun, Tieying
AU - Shan, Guangliang
AU - Yang, Ting
AU - Lin, Yingxiang
AU - Wu, Sinan
AU - Zhu, Jianguo
AU - Wang, Ruiying
AU - Shi, Zhihong
AU - Zhao, Jianping
AU - Ye, Xianwei
AU - Song, Yuanlin
AU - Wang, Qiuyue
AU - Zhou, Yumin
AU - Ding, Liren
AU - Yang, Ting
AU - Chen, Yahong
AU - Guo, Yanfei
AU - Xiao, Fei
AU - Lu, Yong
AU - Peng, Xiaoxia
AU - Zhang, Biao
AU - Xiao, Dan
AU - Chen, Chung Shiuan
AU - Wang, Zuomin
AU - Zhang, Hong
AU - Bu, Xiaoning
AU - Zhang, Xiaolei
AU - An, Li
AU - Zhang, Shu
AU - Cao, Zhixin
AU - Zhan, Qingyuan
AU - Yang, Yuanhua
AU - Cao, Bin
AU - Dai, Huaping
AU - Liang, Lirong
AU - He, Jiang
N1 - Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2018/4/28
Y1 - 2018/4/28
N2 - Background: Although exposure to cigarette smoking and air pollution is common, the current prevalence of chronic obstructive pulmonary disease (COPD) is unknown in the Chinese adult population. We conducted the China Pulmonary Health (CPH) study to assess the prevalence and risk factors of COPD in China. Methods: The CPH study is a cross-sectional study in a nationally representative sample of adults aged 20 years or older from ten provinces, autonomous regions, and municipalities in mainland China. All participants underwent a post-bronchodilator pulmonary function test. COPD was diagnosed according to 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Findings: Between June, 2012, and May, 2015, 57 779 individuals were invited to participate, of whom 50 991 (21 446 men and 29 545 women) had reliable post-bronchodilator results and were included in the final analysis. The overall prevalence of spirometry-defined COPD was 8·6% (95% CI 7·5–9·9), accounting for 99·9 (95% CI 76·3–135·7) million people with COPD in China. Prevalence was higher in men (11·9%, 95% CI 10·2–13·8) than in women (5·4%, 4·6–6·2; p<0·0001 for sex difference) and in people aged 40 years or older (13·7%, 12·1–15·5) than in those aged 20–39 years (2·1%, 1·4–3·2; p<0·0001 for age difference). Only 12·0% (95% CI 8·1–17·4) of people with COPD reported a previous pulmonary function test. Risk factors for COPD included smoking exposure of 20 pack-years or more (odds ratio [OR] 1·95, 95% CI 1·53–2·47), exposure to annual mean particulate matter with a diameter less than 2·5 μm of 50–74 μg/m3 (1·85, 1·23–2·77) or 75 μg/m3 or higher (2·00, 1·36–2·92), underweight (body-mass index <18·5 kg/m2; 1·43, 1·03–1·97), sometimes childhood chronic cough (1·48, 1·14–1·93) or frequent cough (2·57, 2·01–3·29), and parental history of respiratory diseases (1·40, 1·23–1·60). A lower risk of COPD was associated with middle or high school education (OR 0·76, 95% CI 0·64–0·90) and college or higher education (0·47, 0·33–0·66). Interpretation: Spirometry-defined COPD is highly prevalent in the Chinese adult population. Cigarette smoking, ambient air pollution, underweight, childhood chronic cough, parental history of respiratory diseases, and low education are major risk factors for COPD. Prevention and early detection of COPD using spirometry should be a public health priority in China to reduce COPD-related morbidity and mortality. Funding: Ministry of Health and Ministry of Science and Technology of China.
AB - Background: Although exposure to cigarette smoking and air pollution is common, the current prevalence of chronic obstructive pulmonary disease (COPD) is unknown in the Chinese adult population. We conducted the China Pulmonary Health (CPH) study to assess the prevalence and risk factors of COPD in China. Methods: The CPH study is a cross-sectional study in a nationally representative sample of adults aged 20 years or older from ten provinces, autonomous regions, and municipalities in mainland China. All participants underwent a post-bronchodilator pulmonary function test. COPD was diagnosed according to 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Findings: Between June, 2012, and May, 2015, 57 779 individuals were invited to participate, of whom 50 991 (21 446 men and 29 545 women) had reliable post-bronchodilator results and were included in the final analysis. The overall prevalence of spirometry-defined COPD was 8·6% (95% CI 7·5–9·9), accounting for 99·9 (95% CI 76·3–135·7) million people with COPD in China. Prevalence was higher in men (11·9%, 95% CI 10·2–13·8) than in women (5·4%, 4·6–6·2; p<0·0001 for sex difference) and in people aged 40 years or older (13·7%, 12·1–15·5) than in those aged 20–39 years (2·1%, 1·4–3·2; p<0·0001 for age difference). Only 12·0% (95% CI 8·1–17·4) of people with COPD reported a previous pulmonary function test. Risk factors for COPD included smoking exposure of 20 pack-years or more (odds ratio [OR] 1·95, 95% CI 1·53–2·47), exposure to annual mean particulate matter with a diameter less than 2·5 μm of 50–74 μg/m3 (1·85, 1·23–2·77) or 75 μg/m3 or higher (2·00, 1·36–2·92), underweight (body-mass index <18·5 kg/m2; 1·43, 1·03–1·97), sometimes childhood chronic cough (1·48, 1·14–1·93) or frequent cough (2·57, 2·01–3·29), and parental history of respiratory diseases (1·40, 1·23–1·60). A lower risk of COPD was associated with middle or high school education (OR 0·76, 95% CI 0·64–0·90) and college or higher education (0·47, 0·33–0·66). Interpretation: Spirometry-defined COPD is highly prevalent in the Chinese adult population. Cigarette smoking, ambient air pollution, underweight, childhood chronic cough, parental history of respiratory diseases, and low education are major risk factors for COPD. Prevention and early detection of COPD using spirometry should be a public health priority in China to reduce COPD-related morbidity and mortality. Funding: Ministry of Health and Ministry of Science and Technology of China.
UR - http://www.scopus.com/inward/record.url?scp=85045110568&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045110568&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(18)30841-9
DO - 10.1016/S0140-6736(18)30841-9
M3 - Article
C2 - 29650248
AN - SCOPUS:85045110568
SN - 0140-6736
VL - 391
SP - 1706
EP - 1717
JO - The Lancet
JF - The Lancet
IS - 10131
ER -